Clinical Trial Update: A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mg [Phase 4]

View source ↗

Summary

This trial update announces the completion of a Phase 4 study evaluating semen characteristics after 9 months of daily tadalafil 20 mg in men with erectile dysf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Erectile Dysfunction | Phase 4 | Status: COMPLETED